Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Elopak Asa has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. Both actions are situated within 1 distinct art unit, which suggests a consistent technical focus for these applications. However, the company must navigate the preferences of 2 distinct examiners, as each pending action is assigned to a different person. This requires a strategy that balances the technical consistency of the 1 distinct art unit with the individual styles of the 2 distinct examiners. The concentration in the art unit may allow for shared technical arguments.
MELARAGNO, MICHAEL is the busiest examiner for this portfolio, overseeing 1 pending office action. The presence of multiple examiners for the 2 pending office actions means that no individual controls the company's prosecution outcomes. Practitioners should focus on the specific requirements of the 1 distinct art unit while addressing the unique feedback provided by the examiners involved. MELARAGNO, MICHAEL is responsible for 1 pending office action, and the outcome will depend on the specific standards of the assigned unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MELARAGNO, MICHAEL | 1 | 67.4% | +11.7% |
| DEMEREE, CHRISTOPHER R | 1 | 68.9% | +14.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704946 | PAPERBOARD-BASED CONTAINER | DEMEREE, CHRISTOPHER R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19023683 | CLOSURE DEVICE FOR ASEPTIC LIQUID CONTAINING CONTAINERS | MELARAGNO, MICHAEL | — |
| 18704946 | PAPERBOARD-BASED CONTAINER | DEMEREE, CHRISTOPHER R | — |
| Art Unit | Apps |
|---|---|
| 3734 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19023683 | CLOSURE DEVICE FOR ASEPTIC LIQUID CONTAINING CONTAINERS | MELARAGNO, MICHAEL | — | DP | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18704946 | PAPERBOARD-BASED CONTAINER | DEMEREE, CHRISTOPHER R | 3734 | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial